Last reviewed · How we verify

NCT03972839: COMPADDI

Comparison of Two D-Dimers Dosing Techniques

Completed Last updated 7 June 2021
What this trial tests

trial in Blood Coagulation Disorder in 3,027 participants. Completed in 1 January 2021.

Timeline
1 July 2019
Primary endpoint
1 July 2020
1 January 2021

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3,027
Start date1 July 2019
Primary completion1 July 2020
Estimated completion1 January 2021
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Blood Coagulation Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study of the possibility of substitution of the automated STAGO D-Dimers method with the semi-automated VIDAS method, which is more expensive, longer to implement and requires the use of a dedicated automaton.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Coagulation Disorder

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03972839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing